Therefore, it would be informative to validate additional genetic factors, including miRNAs, that are involved in modulating HIF-1α level in collaboration with mesenchymal markers to potentially help predict risk of aggressive lung cancer. The gene discussed is HIF1A; the disease is lung carcinoma.